Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,517	13,820	12,946	11,482	8,080	8,955
Market Cap Growth	-1.08%	6.75%	12.75%	42.11%	-9.78%	-9.54%
Enterprise Value	12,882	12,878	12,124	10,966	7,766	8,528
Last Close Price	135.57	136.50	131.76	119.44	85.17	95.85
PE Ratio	32.34	40.49	51.85	74.32	90.18	21.99
Forward PE	15.17	18.15	21.34	22.53	24.55	22.30
PS Ratio	5.02	5.87	6.86	7.71	7.13	8.56
PB Ratio	4.50	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	4.55	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	22.79	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	21.23	23.21	33.20	33.83	31.50	39.19
PEG Ratio	0.72	0.31	0.65	0.66	0.37	0.37
EV/Sales Ratio	4.80	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	22.60	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	23.84	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	21.72	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.16	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.81	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.69	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	17.15	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.89	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.38	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.96%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.66%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	10.41%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	3.17%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	4.39%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	1.30%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q